Israeli company develops new technology that can destroy cancerous tumors
The developer, IceCure, has several staff members who are graduates of the Technion – the Israel Institute of Technology.
By JERUSALEM POST STAFFA radiologist examines breast X-rays after a cancer prevention medical check-up at the Ambroise Pare hospital in Marseille(photo credit: JEAN-PAUL PELISSIER / REUTERS)
Israeli medical device company IceCure has developed a new technology called ProSense, which it says has proven extremely effective in treating women with breast cancer, the company said in a press release on Thursday.ProSense was created to find a non-surgical and less invasive alternative which can destroy tumors by using cryotherapy technology.It utilizes a probe that is inserted into the tumor and freezes it by lowering its temperature, leaving the healthy tissue around it while alternating between freezing and thawing the specific area of the tumor. The technology has been referred to as a "breakthrough device" by the US Food and Drug Administration (FDA), which officially recognized the innovation last month as having the capabilities to save lives.CEO of Technion UK, Alan Aziz, stated that "invasive surgery was the only possibility for removing tumors, but [IceCure researchers] are looking to put those old methods on ice.”Around 700,000 people die every year from breast cancer.
